Molds and yeasts enumeration is a core microbiological safety test required for health foods and dietary supplements, detecting viable fungal contamination that can cause product spoilage and signal potential mycotoxin risk. This technical article explains the testing principle, applicable standards such as GB 4789.15-2016 and ISO 21527, sample types, analytical procedures, result interpretation, and the main regulatory and quality-control applications of molds and yeasts determination in health food products.
Technical Overview
The determination of molds and yeasts in health foods is a quantitative microbiological test that enumerates viable fungal cells in a sample, with results expressed as colony-forming units per gram or per milliliter (CFU/g or CFU/mL). Together with the total aerobic plate count and coliform detection, it is one of the fundamental hygiene indicators used to judge the microbiological quality and safety of dietary supplements and functional food products.
Health foods are particularly susceptible to fungal contamination because they frequently rely on botanical raw materials, herbal powders, plant and protein extracts, starches, and gelatin or starch capsules, all of which can carry molds and yeasts from soil, air, drying facilities, or storage environments. Many finished products also have low water activity, which selectively favors xerophilic molds such as Aspergillus, Penicillium, and Wallemia species capable of slow growth during long shelf lives.
The consequences of excessive fungal loads include visible spoilage, off-odors, gas formation, degradation of active ingredients, and, in the case of mycotoxigenic species, the potential production of harmful secondary metabolites such as aflatoxins and ochratoxin A. Because health foods are often consumed by elderly, immunocompromised, or chronically ill populations, regulatory authorities impose strict microbiological limits. In China, the national food safety standard for health foods (GB 16740-2014) establishes sampling plans and maximum permitted levels for molds and yeasts, with exemptions or special provisions for products that intentionally contain viable microorganisms. Equivalent international frameworks include ISO 21527, the USP microbial enumeration test, and the FDA Bacteriological Analytical Manual.
The analytical principle is straightforward: a measured portion of the sample is homogenized in a sterile diluent, serially diluted, mixed with or plated onto a selective agar medium that suppresses bacteria while supporting fungal growth, and incubated at moderate temperature for several days. Colonies are then counted, corrected for dilution, and reported as an estimate of the viable yeast and mold population in the original product.
Testing Samples
Solid and Semi-Solid Dosage Forms
Tablets, hard and soft capsules, pills, granules, effervescent formulations, powdered drinks, and botanical tea bags represent the largest share of tested matrices. Representative units from a batch are combined or individually prepared, and solid forms may be ground or dissolved to ensure a homogeneous suspension before dilution. Low-moisture products may require special media to recover xerophilic fungi effectively.
Liquid and Viscous Products
Oral liquids, nutrient beverages, syrups, tinctures, emulsions, and honey-based or paste-type formulations are tested by measuring a defined volume and homogenizing it in the diluent. Viscous or oily matrices may require warming, surfactant addition, or vigorous homogenization to achieve complete dispersion of microorganisms.
Special Matrices
Probiotic and other live-culture products contain high populations of bacteria or yeasts, so selective media and incubation conditions must suppress the intended organisms while allowing contaminant fungi to be recovered. High-fat softgel fills, high-sugar concentrates, alcohol-containing tinctures, and deeply pigmented herbal extracts can all interfere with recovery or colony observation and demand matrix-specific method adaptations.
Raw Materials and Environmental Samples
Incoming botanical powders, extracts, excipients, and packaging components are commonly tested as part of supplier qualification programs, while environmental swabs, contact plates, and settle plates from production areas support GMP hygiene monitoring and contamination investigations.
Testing Items
The primary testing item is the enumeration of viable yeasts and molds, reported as CFU/g or CFU/mL. Depending on the product specification, the laboratory may report the combined count or separate mold and yeast counts based on colony morphology. Supplementary items frequently requested alongside the enumeration include:
- Total combined yeasts and molds count for release testing against finished-product specifications
- Separate mold count and yeast count where the applicable standard distinguishes the two indicators
- Preliminary characterization of predominant colonies by macroscopic and microscopic morphology, with optional genus- or species-level identification by molecular methods when contamination investigations require it
- Related chemical analyses such as aflatoxins B1, B2, G1, and G2, ochratoxin A, water activity, and moisture content, which are often evaluated together with fungal counts to fully characterize contamination risk
Testing Methods
GB 4789.15-2016 Plate Count Method
The Chinese national food safety standard method is the reference procedure for health foods marketed in China and follows a conventional plate-count workflow:
- Aseptically weigh 25 g or measure 25 mL of sample and homogenize with 225 mL of sterile diluent (0.85% sterile saline or phosphate buffer) to prepare the initial 1:10 dilution
- Prepare further serial tenfold dilutions as appropriate for the expected contamination level
- Transfer 1 mL of each selected dilution into duplicate sterile Petri dishes, add 15 to 20 mL of molten rose bengal medium cooled to approximately 46 °C, and mix thoroughly by rotation
- Allow the agar to solidify, invert the plates, and incubate at 28 ± 1 °C for 5 days, with an intermediate observation at day 3 to monitor growth
- Select plates yielding between 10 and 150 colonies, count the colonies, average the duplicates, multiply by the dilution factor, and report the result as CFU/g or CFU/mL, applying standard rounding rules
Rose bengal medium contains chloramphenicol and the rose bengal dye, which suppress bacterial growth and restrict the spreading of fast-growing mold colonies, making counts more accurate and reproducible. When no colonies appear in the lowest dilution, results are reported as below the corresponding detection threshold, for example fewer than 10 CFU/g.
ISO 21527 Series
ISO 21527-1 specifies a colony-count technique on dichloran rose bengal chloramphenicol (DRBC) agar with incubation at 25 °C for 5 days, intended for products with water activity greater than 0.95. ISO 21527-2 uses dichloran 18% glycerol (DG18) agar with incubation at 25 °C for 5 to 7 days and is designed for low-moisture products with water activity of 0.95 or below, where xerophilic fungi must be recovered. Matching the medium to the water activity of the product is essential for meaningful results in dried tablets, capsules, and powdered supplements.
Pharmacopeial and BAM-Based Methods
For supplement-grade products governed by pharmacopeial microbiology, the total combined yeasts and molds count is performed according to the microbial enumeration test described in USP General Chapter 61, which offers pour-plate, spread-plate, and membrane-filtration options with incubation on Sabouraud dextrose or rose bengal-based media. The FDA Bacteriological Analytical Manual, Chapter 18, provides alternative procedures using acidified potato dextrose agar and DRBC agar and is widely referenced in North American testing programs.
Method Selection and Special Considerations
Accredited third-party laboratories select the method based on the destination market, product matrix, and applicable specification. Key technical considerations include adequate homogenization of capsules and tablets, recovery validation for low-moisture matrices, suppression of probiotic organisms in live-culture products, and consistent handling of spreading colonies, which are counted in a representative manner rather than as individual colonies. Each analytical run includes sterility controls, media performance checks with reference strains, and calibrated incubation temperatures to guarantee data reliability.
Applications
Molds and yeasts determination supports the entire life cycle of a health food product, from development to post-market surveillance:
- Product registration and filing dossiers, where official microbiological test reports demonstrate conformity with the applicable national standard for health foods
- Routine quality-control release testing of finished batches against in-house or compendial specifications before shipment
- Shelf-life and stability studies, which track fungal counts across storage conditions and time points to justify the proposed expiry period
- Raw material and supplier qualification programs for botanical powders, extracts, and excipients that carry inherent fungal bioburden
- Contamination investigations and root-cause analysis following out-of-specification results, consumer complaints, or spoilage incidents
- GMP environmental hygiene monitoring of production areas, equipment, and cleanrooms, together with verification of corrective actions
- Import and export compliance verification, where certificates of analysis based on internationally recognized methods facilitate market access
FAQ
Why are molds and yeasts tested separately from the total aerobic plate count?
The aerobic plate count targets mainly bacteria, while many bacteria are inhibited by the selective media, lower incubation temperature, and longer incubation time used for fungi. A dedicated enumeration therefore provides a true picture of the fungal population, which behaves differently from bacteria in growth kinetics, spoilage behavior, and toxin-producing potential.
What are the typical acceptance criteria?
Limits are defined by the applicable product standard. The Chinese national standard for health foods sets stringent sampling plans and maximum levels for molds and, where relevant, yeasts, commonly in the range of tens of CFU per gram depending on the product form. Products containing deliberately added viable microorganisms are generally exempt from, or subject to special provisions for, these indicators. Always verify the specific limit applicable to the individual product registration file.
How long does the test take?
Because fungi grow slowly, the incubation period is 5 to 7 days depending on the method, and low-moisture products tested under ISO 21527-2 require the full 7 days. Including sample preparation, incubation, counting, verification, and reporting, accredited third-party laboratories typically issue results within 7 to 10 working days from sample receipt.
How are probiotic products handled?
For products containing lactic acid bacteria or other bacterial cultures, the selective medium and incubation conditions suppress the probiotic organisms, allowing contaminant molds and yeasts to be enumerated without interference. For products that intentionally contain yeasts, the yeast indicator is not applicable, and any specification must be adjusted accordingly by the manufacturer and the registration authority.
What does an out-of-specification result mean in practice?
An excessive fungal count indicates compromised hygiene, inadequate drying or storage, defective packaging, or contaminated raw materials, even before visible spoilage appears. The batch should be quarantined and investigated, and because elevated mold counts correlate with an increased risk of mycotoxin formation, additional testing for aflatoxins and related toxins is strongly recommended.
Is a mold and yeast count the same as a mycotoxin test?
No. Enumeration measures the number of viable fungal cells present at the time of testing, whereas mycotoxin analysis chemically quantifies toxic metabolites that may persist even after the producing organisms are no longer viable. The two tests are complementary and are frequently performed together for a complete fungal risk assessment.